Development asset linked to Vor Biopharma in public FDA and regional records.
biotech · Generalized Myasthenia Gravis · Leukemia, Myeloid, Acute · VOR
Vor Biopharma
Vor Biopharma drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Cambridge, USA HQ
110 Employees
Public company Type
VOR · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Employees
- 110
- Programs
- 6
- Drugs
- 4
- Patents
- 12
Vor Biopharma pipeline
Portfolio lens on 4 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Vor Biopharma drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Vor Biopharma in public FDA and regional records.
-
Development asset linked to Vor Biopharma in public FDA and regional records.
-
Development asset linked to Vor Biopharma in public FDA and regional records.